» Articles » PMID: 28993774

The Clinical Application of MicroRNAs in Infectious Disease

Overview
Journal Front Immunol
Date 2017 Oct 11
PMID 28993774
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are short single-stranded non-coding RNA sequences that posttranscriptionally regulate up to 60% of protein encoding genes. Evidence is emerging that miRNAs are key mediators of the host response to infection, predominantly by regulating proteins involved in innate and adaptive immune pathways. miRNAs can govern the cellular tropism of some viruses, are implicated in the resistance of some individuals to infections like HIV, and are associated with impaired vaccine response in older people. Not surprisingly, pathogens have evolved ways to undermine the effects of miRNAs on immunity. Recognition of this has led to new experimental treatments, RG-101 and Miravirsen-hepatitis C treatments which target host miRNA. miRNAs are being investigated as novel infection biomarkers, and they are being used to design attenuated vaccines, e.g., against Dengue virus. This comprehensive review synthesizes current knowledge of miRNA in host response to infection with emphasis on potential clinical applications, along with an evaluation of the challenges still to be overcome.

Citing Articles

Combinatorial Analysis of miRNAs and tRNA Fragments as Potential Biomarkers for Cancer Patients in Liquid Biopsies.

Glogovitis I, DAmbrosi S, Antunes-Ferreira M, Chiogna M, Yahubyan G, Baev V Noncoding RNA. 2025; 11(1).

PMID: 39997617 PMC: 11858735. DOI: 10.3390/ncrna11010017.


Extracellular viral microRNAs as biomarkers of virus infection in human cells.

Chan C, Loh J, Sin W, Teo D, Tan N, Nagarajan C Mol Ther Nucleic Acids. 2025; 36(1):102444.

PMID: 39897577 PMC: 11787021. DOI: 10.1016/j.omtn.2024.102444.


Understanding microRNAs in the context of bacterial versus viral infections.

Milhelm Z, Chiroi P, Harangus A, Dudea M, Ciocan C, Pop L Med Pharm Rep. 2024; 97(4):438-445.

PMID: 39502766 PMC: 11534382. DOI: 10.15386/mpr-2817.


Determination of the role of miR-451a on Plasmodium falciparum red blood cell stages, oxidative stress, and proteomic profiling.

Joshi U, George L, Highland H Mol Biol Rep. 2024; 51(1):1041.

PMID: 39373748 DOI: 10.1007/s11033-024-09938-z.


Small RNA sequencing analysis reveals regulation of microRNA expression in Madin-Darby canine kidney epithelial cells infected with Canid alphaherpesvirus 1.

Ben Hamouda M, Pearson A Virus Genes. 2024; 60(5):537-548.

PMID: 39017941 DOI: 10.1007/s11262-024-02091-6.


References
1.
Tay H, Kaiko G, Plank M, Li J, Maltby S, Essilfie A . Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lung. PLoS Pathog. 2015; 11(4):e1004549. PMC: 4404141. DOI: 10.1371/journal.ppat.1004549. View

2.
Vickers K, Palmisano B, Shoucri B, Shamburek R, Remaley A . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-33. PMC: 3074610. DOI: 10.1038/ncb2210. View

3.
Heiss B, Maximova O, Pletnev A . Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J Virol. 2010; 85(4):1464-72. PMC: 3028900. DOI: 10.1128/JVI.02091-10. View

4.
Cheong J, Shin H, Kim Y, Cho S . Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. J Med Virol. 2013; 85(5):808-14. DOI: 10.1002/jmv.23551. View

5.
Bai X, Nicot C . miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection. J Biol Chem. 2015; 290(9):5381-90. PMC: 4342455. DOI: 10.1074/jbc.M114.626325. View